使用转录组技术解读正常和疾病的大动脉生物学的最新进展
Monica Madalina Tucureanu1, Ileana Manduteanu1
1Institute of Cellular Biology and Pathology "Nicolae Simionescu", Bucharest, Romania.
Journal of cellular and molecular medicine
|September 4, 2025
概括
动脉疾病 (CAVD) 缺乏治疗方法. 本综述使用转录学来探索大动脉 (AV) 细胞生物学,确定CAVD的潜在治疗点.
科学领域:
- 心血管生物学
- 基因组学
- 翻译医学
背景情况:
- 在目前没有药物治疗的情况下,动脉病 (CAVD) 构成了全球重大健康挑战.
- 了解大动脉的复杂细胞和分子机制对于开发有效疗法至关重要.
研究的目的:
- 审查近期了解AVD的结构,功能和细胞动态的进展.
- 通过转录组数据识别和优先考虑用于CAVD治疗的分子点.
主要方法:
- 使用转录组方法,包括RNA测序 (RNAseq) 和单细胞测序 (scRNAseq).
- 分析膜细胞的可塑性,异质性和细胞间相互作用 (例如,膜内皮细胞和单细胞之间的相互作用).
- 整合发现以描述基线AV过程和与疾病相关的变化.
主要成果:
- 转录组研究显示AV细胞中复杂的细胞异质性和可塑性.
- 膜内皮细胞与单细胞之间的相互作用在CAVD的发病过程中具有关键性.
- 已经确定了与CAVD进展有关的关键分子标.
结论:
- 转录的洞察力对于理解CAVD机制和确定治疗策略至关重要.
- 需要通过实验研究进一步验证已识别的分子标.
- 这一审查为开发CAVD新药治疗提供了基础.
相关概念视频
01:15Aortic Regurgitation I: Introduction
36
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
36
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
52
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52